Silver Book Fact

Fact image

The Impact of Personalized Medicine on Cancer Survival in Years

Munoz, J and R Kurzrock. Targeted Therapy in Rare Cancers: Adopting the orphans. Nat Rev Clin Oncol. 2012; 9(11): 631-42. http://www.ncbi.nlm.nih.gov/pubmed/22965154

Reference

Title
Targeted Therapy in Rare Cancers: Adopting the orphans
Publication
Nat Rev Clin Oncol
Publication Date
2012
Authors
Munoz, J and R Kurzrock
Volume & Issue
Volume 9, Issue 11
Pages
631-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The overall five-year survival rate for men with prostate cancer is 99 percent—up from 43 percent in 1975.  
  • FDA approved cancer advances
     
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.  
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • Use of a monocolonal antibody with adjuvant chemotherapy in HER2+ individuals with operable cancer was associated with a 33 percent reduction in risk of death.